Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SMALL CELL LUNG CARCINOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT01993810
What this trial is testing

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Who this might be right for
Stage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7Stage IIB Non-Small Cell Lung Carcinoma AJCC v7+3 more
Radiation Therapy Oncology Group 330
Not applicableLooking for participantsNCT05834413
What this trial is testing

Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

Who this might be right for
Lung Cancer
Shanghai University of Traditional Chinese Medicine 367
Testing effectiveness (Phase 2)WithdrawnNCT06522360
What this trial is testing

Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)

Who this might be right for
Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04964960
What this trial is testing

Pembro+Chemo in Brain Mets

Who this might be right for
Lung CancerLung Cancer MetastaticBrain Cancer+1 more
John L. Villano, MD, PhD 3
Not applicableEnded earlyNCT03607682
What this trial is testing

Tumor-Treating Fields Therapy in Preventing Brain Tumors in Participants With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Carcinoma
Vanderbilt-Ingram Cancer Center 2
Not applicableEnded earlyNCT01865903
What this trial is testing

Nutritional Problems and Changes in Body Composition in Patients With Non-small Cell Lung Cancer (LEKS)

Who this might be right for
Weight LossCachexia
Oslo University Hospital 17
Early research (Phase 1)Ended earlyNCT00955942
What this trial is testing

Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Lung CancerRadiation Toxicity
Abramson Cancer Center at Penn Medicine 48
Large-scale testing (Phase 3)Study completedNCT00446225
What this trial is testing

Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR

Who this might be right for
Non-Small Cell Lung Cancer
Spanish Lung Cancer Group 174
Large-scale testing (Phase 3)Looking for participantsNCT07472517
What this trial is testing

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

Who this might be right for
Small Cell Lung Cancer (SCLC)Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Boehringer Ingelheim 670
Testing effectiveness (Phase 2)Study completedNCT02659059
What this trial is testing

Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Bristol-Myers Squibb 324
Testing effectiveness (Phase 2)UnknownNCT03349203
What this trial is testing

Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer

Who this might be right for
EGF-R Positive Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT01757288
What this trial is testing

Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC

Who this might be right for
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
University of Texas Southwestern Medical Center 98
Large-scale testing (Phase 3)Not Yet RecruitingNCT07822542
What this trial is testing

A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jiangsu Hansoh Pharmaceutical Co., Ltd. 448
Not applicableEnrolling By InvitationNCT05212103
What this trial is testing

PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9

Who this might be right for
Acute Myeloid LeukemiaMelanomaNon Small Cell Lung Cancer
Turku University Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT04789486
What this trial is testing

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Who this might be right for
Non-small Cell Lung CancerAdvanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer+1 more
Dana-Farber Cancer Institute 100
Not applicableAvailableNCT06761976
What this trial is testing

Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation

Who this might be right for
Advanced Non-small Cell Lung CancerCancer
Bayer
Testing effectiveness (Phase 2)Ended earlyNCT01413750
What this trial is testing

Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIA Lung Non-Small Cell Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7Stage IV Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 23
Not applicableStudy completedNCT05902260
What this trial is testing

The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Joachim Aerts, MD PhD 51
Testing effectiveness (Phase 2)Looking for participantsNCT07269782
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Henlius Biotech 60
Testing effectiveness (Phase 2)Ended earlyNCT00200382
What this trial is testing

Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Rasim Gucalp 27
Next Page